Evidence map›Paper›PMID 39679832›Full record

ArticleDevelopmental medicine and child neurology2025

Natural history of SGCE-associated myoclonus dystonia in children and adolescents.

Valeria De Francesch, Ana Cazurro-Gutiérrez, Elze R Timmers, Gemma Español-Martín, Julia Ferrero-Turrión, David Gómez-Andrés, Anna Marcé-Grau, Lucía Dougherty-de Miguel, Victoria González, Antonio Moreno-Galdó and 2 more

Abstract read
In one paragraph

Article in Developmental medicine and child neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Distinct Brain Drivers and Shared Cerebello-Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Valeria De Francesch *Child and Adolescent Neuropsychiatry Unit, AULSS1 Dolomiti, San Martino Hospital, Belluno, Italy.
Ana Cazurro-Gutiérrez *Innovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Elze R TimmersExpertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Gemma Español-MartínDepartment of Pediatrics, Universitat Autònoma de Barcelona, Barcelona, Spain.
Julia Ferrero-TurriónInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
David Gómez-AndrésInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Anna Marcé-GrauInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Lucía Dougherty-de MiguelInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Victoria GonzálezInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
Antonio Moreno-GaldóDepartment of Pediatrics, Universitat Autònoma de Barcelona, Barcelona, Spain.
Marina A J TijssenExpertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Belén Pérez-DueñasInnovative Therapies in Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.ORCID 0000-0002-4979-2788

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2022 FI_B 00996Instituto de Salud Carlos III FORT23/00034Instituto de Salud Carlos III PI21/00248Instituto de Salud Carlos III PI24/01083Myoclonus Dystonia Spanish association (ALUDME) FORT23/00034Myoclonus Dystonia Spanish association (ALUDME) PI21/00248Myoclonus Dystonia Spanish association (ALUDME) PI24/01083
6 · The paper itself

Abstract

aimTo investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood.

methodMyoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort.

resultsThirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8).

interpretationThis study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae.

Indexed as

Disease ProgressionDystonic DisordersSarcoglycansAdolescentAdultChildChild, PreschoolCohort StudiesCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleNetherlandsSpainYoung AdultSarcoglycansSGCE protein, human

Identifiers

PMID39679832
PMCPMC12066975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.